chr1-12011376-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014874.4(MFN2):c.2205-120C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0759 in 1,046,330 control chromosomes in the GnomAD database, including 3,715 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.080 ( 591 hom., cov: 33)
Exomes 𝑓: 0.075 ( 3124 hom. )
Consequence
MFN2
NM_014874.4 intron
NM_014874.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.828
Publications
12 publications found
Genes affected
MFN2 (HGNC:16877): (mitofusin 2) This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
MFN2 Gene-Disease associations (from GenCC):
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- axonal hereditary motor and sensory neuropathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-12011376-C-G is Benign according to our data. Variant chr1-12011376-C-G is described in ClinVar as Benign. ClinVar VariationId is 1284248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0801 AC: 12187AN: 152108Hom.: 590 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
12187
AN:
152108
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0752 AC: 67266AN: 894104Hom.: 3124 AF XY: 0.0774 AC XY: 35840AN XY: 462984 show subpopulations
GnomAD4 exome
AF:
AC:
67266
AN:
894104
Hom.:
AF XY:
AC XY:
35840
AN XY:
462984
show subpopulations
African (AFR)
AF:
AC:
2372
AN:
22324
American (AMR)
AF:
AC:
1269
AN:
36776
Ashkenazi Jewish (ASJ)
AF:
AC:
895
AN:
22006
East Asian (EAS)
AF:
AC:
5367
AN:
35288
South Asian (SAS)
AF:
AC:
10244
AN:
70618
European-Finnish (FIN)
AF:
AC:
3687
AN:
48472
Middle Eastern (MID)
AF:
AC:
242
AN:
4704
European-Non Finnish (NFE)
AF:
AC:
39912
AN:
612338
Other (OTH)
AF:
AC:
3278
AN:
41578
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3241
6483
9724
12966
16207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1124
2248
3372
4496
5620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0801 AC: 12193AN: 152226Hom.: 591 Cov.: 33 AF XY: 0.0814 AC XY: 6061AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
12193
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
6061
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
4583
AN:
41528
American (AMR)
AF:
AC:
626
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
122
AN:
3470
East Asian (EAS)
AF:
AC:
744
AN:
5178
South Asian (SAS)
AF:
AC:
711
AN:
4828
European-Finnish (FIN)
AF:
AC:
796
AN:
10608
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4376
AN:
67998
Other (OTH)
AF:
AC:
155
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
567
1135
1702
2270
2837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
524
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.